| dc.rights.license | CC-BY-NC-ND | |
| dc.contributor.advisor | Roelfsema, Hein | |
| dc.contributor.author | Pelicarić, Marcela | |
| dc.date.accessioned | 2025-09-01T00:03:27Z | |
| dc.date.available | 2025-09-01T00:03:27Z | |
| dc.date.issued | 2025 | |
| dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/50234 | |
| dc.description.sponsorship | Utrecht University | |
| dc.language.iso | EN | |
| dc.subject | This thesis assesses the strategic feasibility of MPI NutriPharma’s entry into the MENA nutraceutical market. Facing saturation in Europe, MPI targets the region's growth potential amid regulatory, cultural, and competitive complexities. Using expert interviews and strategic frameworks, the study recommends a phased entry via partnerships in the GCC, evolving toward localized production. It offers a practical model for niche firms expanding into fragmented international markets. | |
| dc.title | BARRIERS AND DRIVERS INFLUENCING MPI NUTRIPHARMA'S MARKET ENTRY AND EXPANSION IN THE MENA REGION | |
| dc.type.content | Master Thesis | |
| dc.rights.accessrights | Open Access | |
| dc.subject.courseuu | Science and Business Management | |
| dc.thesis.id | 53168 | |
